Carry out precise and effective neuromodulation interventions, and develop new neuromodulation technologies for sleep disorders. Use phototherapy, transcranial electrical/magnetic stimulation and other therapies to conduct self-controlled intervention studies on insomnia, narcolepsy, and rapid eye movement sleep behavior disorder .
None
Patients with major neurological diseases such as multi-infarct dementia, Huntington's disease, normal pressure hydrocephalus, brain tumors, progressive supranuclear palsy, epilepsy, subdural hematoma, multiple sclerosis, or those who have sustained neurological dysfunction or known structural brain abnormalities after significant head trauma are excluded.
A history of major depressive disorder or bipolar disorder within the past year, as defined in DSM-IV criteria. A history of schizophrenia (meeting DSM-IV criteria).
History of severe drug or alcohol abuse within the past year;
Any significant systemic illness or unstable medical condition that may make it difficult to comply with the protocol, such as severe autoimmune diseases or a history of cancer.
Single group
Transcranial Magnetic Stimulation
Devicerepetitive transcranial magnetic stimulation, or transcranial direct current stimulation, or daytime timed bright light exposure
Objective sleep indicators and clinical sleep-related scales
Resting-state electroencephalogram, resting-state functional magnetic resonance imaging, blood biochemical indicators
Click on the lead sponsor to view all of their trials.
